Walleye Trading’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-20,600
Closed -$1.75M 5222
2020
Q3
$1.75M Buy
+20,600
New +$1.04M 0.01% 1222
2019
Q4
Sell
-89,200
Closed -$1.18M 4784
2019
Q3
$1.18M Buy
89,200
+87,900
+6,762% +$1.29M 0.01% 1472
2019
Q2
$18K Sell
1,300
-10,400
-89% -$156K ﹤0.01% 3765
2019
Q1
$225K Sell
11,700
-211,000
-95% -$3.4M ﹤0.01% 2935
2018
Q4
$3.18M Buy
222,700
+201,600
+955% +$4M 0.02% 730
2018
Q3
$440K Sell
21,100
-21,000
-50% -$497K ﹤0.01% 3031
2018
Q2
$997K Buy
42,100
+15,400
+58% +$310K 0.01% 2107
2018
Q1
$390K Buy
+26,700
New +$436K ﹤0.01% 2915
2017
Q4
Sell
-6,900
Closed -$97 4776
2017
Q3
$97 Buy
6,900
+300
+5% +$2.99K ﹤0.01% 3624
2017
Q2
$58 Buy
+6,600
New +$46.3K ﹤0.01% 3823

Walleye Trading's IMMU Position: Q4 2020 in Review

Walleye Trading sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 10,449 shares — an estimated $888K sold.

Walleye Trading first reported a position in IMMU in Q2 2015 and held it in 5 quarters. The position peaked at $888K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Walleye Trading reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Walleye Trading sold 10,449 Immunomedics Inc shares in Q4 2020, an estimated $888K.
  • Walleye Trading first reported a position in Immunomedics Inc in Q2 2015 and held it in 5 quarters.
  • Walleye Trading's Immunomedics Inc position peaked at $888K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Walleye Trading's 13F filing for Q4 2020, filed 16 Feb 2021.